Peptomyc Announces the Approval of Its Phase 1b Trial Testing OMO-103 in Combination With Standard of Care in PDAC Patients
OMO-103 in Phase 1b clinical trial Peptomyc S.L., a biotech company specialized in the development of protein therapeutics for cancer treatment, announces that it has...
Germany Issues Award to IAVI to Support Development of the MTBVAC Tuberculosis Vaccine Candidate
NEW YORK, NY / ACCESSWIRE / July 7, 2023 / IAVI is pleased to announce that a new award has been granted by the German...
Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides
SHELTON, CO / ACCESSWIRE / July 6, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") reports that the clinical trial of its broad-spectrum antiviral drug...
NanoViricides Has Shipped Drug Products for Impending Clinical Trials of NV-CoV-2, Its COVID Drug Candidate
SHELTON, CT / ACCESSWIRE / April 17, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in nanomedicines against viruses, announced...
Nanomerics Announces Ocular Molecular Envelope Technology (MET) Patent Granted in Canada
LONDON, UK / ACCESSWIRE / April 13, 2023 / Nanomerics Ltd., a private speciality pharmaceutical company today announced that the Company had been granted patent...
IQ-AI Announces Orphan Drug Designation Status
MILWAUKEE, WI / ACCESSWIRE / February 28, 2023 / IQ-AI Limited, (OTCQB:IQAIF)(LSE:IQAI), and its US-based subsidiary, Imaging Biometrics, LLC (Milwaukee, WI) is pleased to announce...
Faro Health Secures $20 Million to Scale the Digital Transformation of Clinical Studies
Faro Health Inc., a cloud-computing company that is developing digital infrastructure for smart clinical trials, today announced $20 million in additional funding. The round was...